The cholinergic enhancing drugs Cognex (tacrine) and Aricept (donepezil) have recently been approved for the treatment of
A)Parkinson's disease
B)Alzheimer's disease
C)schizophrenia
D)childhood autism

Question

Quizplus · Accepted Answer

Cognex and Aricept are cholinergic enhancing drugs that have been approved for the treatment of Alzheimer's disease, a neurodegenerative disorder that affects memory and cognitive processes. They work by increasing levels of the neurotransmitter acetylcholine in the brain, which is known to be deficient in individuals with Alzheimer's disease. These drugs are not approved for the treatment of Parkinson's disease, schizophrenia, or childhood autism.

The Cholinergic Enhancing Drugs Cognex (Tacrine) and Aricept (Donepezil) Have